Human Molecular Genetics, 2000, Vol. 9, No. 8 1145-1159
© 2000 Oxford University Press
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA, 1Department of Chemistry and 2Howard Hughes Medical Institute, Emory University School of Medicine, Atlanta, GA 30322, USA
Fragile X syndrome is a common cause of mental retardation involving loss of expression of the FMR1 gene. The role of FMR1 remains undetermined but the protein appears to be involved in RNA metabolism. Fmr1 knockout mice exhibit a phenotype with some similarities to humans, such as macroorchidism and behavioral abnormalities. As a step toward understanding the function of FMR1 and the determination of the potential for therapeutic approaches to fragile X syndrome, yeast artificial chromosome (YAC) transgenic mice were generated in order to determine whether the Fmr1 knockout mouse phenotype could be rescued. Several transgenic lines were generated that carried the entire FMR1 locus with extensive amounts of flanking sequence. We observed that the YAC transgene supported production of the human protein (FMRP) which was present at levels 10 to 15 times that of endogenous protein and was expressed in a cell- and tissue-specific manner. Macroorchidism was absent in knockout mice carrying the YAC transgene indicating functional rescue by the human protein. Given the complex behavioral phenotype in fragile X patients and the mild phenotype previously reported for the Fmr1 knockout mouse, we performed a more thorough evaluation of the Fmr1 knockout phenotype using additional behavioral assays that had not previously been reported for this animal model. The mouse displayed reduced anxiety-related responses with increased exploratory behavior. FMR1 YAC transgenic mice overexpressing the human protein did produce opposing behavioral responses and additional abnormal behaviors were also observed. These findings have significant implications for gene therapy for fragile X syndrome since overexpression of the gene may harbor its own phenotype.
+ To whom correspondence should be addressed. Tel: +1 713 798 8854; Fax: +1 713 798 5386; Email: nelson@bcm.tmc.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Pilpel, A. Kolleker, S. Berberich, M. Ginger, A. Frick, E. Mientjes, B. A. Oostra, and P. H. Seeburg Synaptic ionotropic glutamate receptors and plasticity are developmentally altered in the CA1 field of Fmr1 knockout mice J. Physiol., February 15, 2009; 587(4): 787 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zupan and M. Toth Inactivation of the Maternal Fragile X Gene Results in Sensitization of GABAB Receptor Function in the Offspring J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 820 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Vessey, P. Macchi, J. M. Stein, M. Mikl, K. N. Hawker, P. Vogelsang, K. Wieczorek, G. Vendra, J. Riefler, F. Tubing, et al. A loss of function allele for murine Staufen1 leads to impairment of dendritic Staufen1-RNP delivery and dendritic spine morphogenesis PNAS, October 21, 2008; 105(42): 16374 - 16379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Bureau, G. M. G. Shepherd, and K. Svoboda Circuit and Plasticity Defects in the Developing Somatosensory Cortex of Fmr1 Knock-Out Mice J. Neurosci., May 14, 2008; 28(20): 5178 - 5188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Khelfaoui, C. Denis, E. van Galen, F. de Bock, A. Schmitt, C. Houbron, E. Morice, B. Giros, G. Ramakers, L. Fagni, et al. Loss of X-Linked Mental Retardation Gene Oligophrenin1 in Mice Impairs Spatial Memory and Leads to Ventricular Enlargement and Dendritic Spine Immaturity J. Neurosci., August 29, 2007; 27(35): 9439 - 9450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Hayashi, B. S. S. Rao, J.-S. Seo, H.-S. Choi, B. M. Dolan, S.-Y. Choi, S. Chattarji, and S. Tonegawa Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice PNAS, July 3, 2007; 104(27): 11489 - 11494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Tucker, R. I. Richards, and M. Lardelli Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome Hum. Mol. Genet., December 1, 2006; 15(23): 3446 - 3458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gheldof, T. M. Tabuchi, and J. Dekker The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications PNAS, August 15, 2006; 103(33): 12463 - 12468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Spencer, E. Serysheva, L. A. Yuva-Paylor, B. A. Oostra, D. L. Nelson, and R. Paylor Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins Hum. Mol. Genet., June 15, 2006; 15(12): 1984 - 1994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Stein, W. Bergman, Y. Fang, L. Davison, C. Brensinger, M. B. Robinson, N. B. Hecht, and T. Abel Behavioral and neurochemical alterations in mice lacking the RNA-binding protein translin. J. Neurosci., February 22, 2006; 26(8): 2184 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-G. Zhao, H. Toyoda, S. W. Ko, H.-K. Ding, L.-J. Wu, and M. Zhuo Deficits in Trace Fear Memory and Long-Term Potentiation in a Mouse Model for Fragile X Syndrome J. Neurosci., August 10, 2005; 25(32): 7385 - 7392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Abrahams, M. C. H. Kwok, E. Trinh, S. Budaghzadeh, S. M. Hossain, and E. M. Simpson Pathological Aggression in "Fierce" Mice Corrected by Human Nuclear Receptor 2E1 J. Neurosci., July 6, 2005; 25(27): 6263 - 6270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Qin, J. Kang, and C. B. Smith Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation PNAS, November 26, 2002; 99(24): 15758 - 15763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mazroui, M.-E. Huot, S. Tremblay, C. Filion, Y. Labelle, and E. W. Khandjian Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression Hum. Mol. Genet., November 15, 2002; 11(24): 3007 - 3017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cabin, K. Shimazu, D. Murphy, N. B. Cole, W. Gottschalk, K. L. McIlwain, B. Orrison, A. Chen, C. E. Ellis, R. Paylor, et al. Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking alpha -Synuclein J. Neurosci., October 15, 2002; 22(20): 8797 - 8807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Gu, K. L. McIlwain, E. J. Weeber, T. Yamagata, B. Xu, B. A. Antalffy, C. Reyes, L. Yuva-Paylor, D. Armstrong, H. Zoghbi, et al. Impaired Conditioned Fear and Enhanced Long-Term Potentiation in Fmr2 Knock-Out Mice J. Neurosci., April 1, 2002; 22(7): 2753 - 2763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. M. Bontekoe, K. L. McIlwain, I. M. Nieuwenhuizen, L. A. Yuva-Paylor, A. Nellis, R. Willemsen, Z. Fang, L. Kirkpatrick, C. E. Bakker, R. McAninch, et al. Knockout mouse model for Fxr2: a model for mental retardation Hum. Mol. Genet., March 1, 2002; 11(5): 487 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, Y. Zhang, L. Ku, K. D. Wilkinson, S. T. Warren, and Y. Feng The fragile X mental retardation protein inhibits translation via interacting with mRNA Nucleic Acids Res., June 1, 2001; 29(11): 2276 - 2283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Laggerbauer, D. Ostareck, E.-M. Keidel, A. Ostareck-Lederer, and U. Fischer Evidence that fragile X mental retardation protein is a negative regulator of translation Hum. Mol. Genet., February 1, 2001; 10(4): 329 - 338. [Abstract] [Full Text] [PDF]
|
|